felbamate has been researched along with Anochlesia in 1 studies
Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the catalepsy test, felbamate antagonized dopamine D2 receptor- but not D1 receptor-induced akinesia." | 1.29 | Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats. ( Kretschmer, BD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kretschmer, BD | 1 |
1 other study available for felbamate and Anochlesia
| Article | Year |
|---|---|
Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.
Topics: Animals; Anticonvulsants; Antiparkinson Agents; Benzazepines; Catalepsy; Dopamine D2 Receptor Antago | 1994 |